Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Cash from Financing Activities (2020 - 2025)

BioAtla's Cash from Financing Activities history spans 6 years, with the latest figure at $6.7 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 27.92% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $6.3 million, down 34.01%, while the annual FY2025 figure was $6.3 million, 34.01% down from the prior year.
  • Cash from Financing Activities reached $6.7 million in Q4 2025 per BCAB's latest filing, up from -$6000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $75.1 million in Q3 2021 to a low of -$3.9 million in Q4 2021.
  • Average Cash from Financing Activities over 5 years is $7.3 million, with a median of -$13500.0 recorded in 2024.
  • Peak YoY movement for Cash from Financing Activities: soared 7726.05% in 2024, then crashed 2938.46% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$3.9 million in 2021, then skyrocketed by 1680.48% to $61.8 million in 2022, then tumbled by 99.81% to $119000.0 in 2023, then skyrocketed by 7726.05% to $9.3 million in 2024, then fell by 27.92% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Cash from Financing Activities are $6.7 million (Q4 2025), -$6000.0 (Q3 2025), and -$36000.0 (Q2 2025).